Home > Healthcare > Lateral Flow Assays Market > Table of Contents

Lateral Flow Assays Market - By Product (Kits, Readers), By Application (Infectious Disease Testing, Cardiac Metabolic Testing, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use & Forecast, 2023-2032

  • Report ID: GMI5147
  • Published Date: Jan 2023
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Methodology

1.2    Market scope and definition

1.3    Base estimates and calculations

1.4    Forecast calculations

1.5    Data sources

1.5.1    Primary

1.5.2    Secondary

1.5.2.1   Paid sources

1.5.2.2   Unpaid sources

Chapter 2   Executive Summary

2.1    Lateral flow assays industry 3600 synopsis, 2018 - 2032

2.1.1    Business trends

2.1.2    Product trends

2.1.3    Application trends

2.1.4    Technique trends

2.1.5    End-use trends

2.1.6    Regional trends

Chapter 3   Lateral Flow Assays Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2018 - 2032

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1   Increasing prevalence of infectious disease

3.3.1.2   Growing demand for point-of-care testing

3.3.1.3   Technological advancements

3.3.2    Industry pitfalls & challenges

3.3.2.1   Low accuracy of results

3.3.2.2   Availability of substitute product

3.3.2.3   Stringent regulatory framework

3.4    Growth potential analysis

3.4.1    By product

3.4.2    By application

3.4.3    By technique

3.4.4    By end-use

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.6.1    U.S.

3.6.2    Europe

3.6.3    China

3.7    Technology landscape

3.8    Porter's analysis

3.9    PESTEL analysis

Chapter 4   Competitive Landscape, 2022

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive positioning matrix

4.4    Strategy dashboard

Chapter 5   Lateral Flow Assays Market, By Product

5.1    Key product trends

5.2    Kits

5.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

5.3    Readers

5.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6   Lateral Flow Assays Market, By Application

6.1    Key application trends

6.2    Infectious disease testing

6.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.2    Influenza

6.2.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.3    Sexually transmitted disease (STD)

6.2.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.4    Hepatitis

6.2.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.5    Tuberculosis

6.2.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.2.6    Others

6.2.6.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3    Cardiac marker testing

6.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.2    Creatine kinase-MB (CK-MB)

6.3.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.3    Myoglobin

6.3.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.4    D-dimer

6.3.4.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.5    Troponin I

6.3.5.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.3.6    Others

6.3.6.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.4    Pregnancy and fertility testing

6.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.4.2    Pregnancy testing

6.4.2.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.4.3    Fertility testing

6.4.3.1   Market estimates and forecast, 2018 - 2032 (USD Million)

6.5    Cholesterol testing

6.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.6    Drug-of-Abuse (DoA) testing

6.6.1    Market estimates and forecast, 2018 - 2032 (USD Million)

6.7    Other

6.7.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7   Lateral Flow Assays Market, By Technique

7.1    Key technique trend

7.2    Sandwich assays

7.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.3    Competitive assays

7.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

7.4    Multiplex detection assays

7.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8   Lateral Flow Assays Market, By End-use

8.1    Key end-use trend

8.2    Hospital & clinics

8.2.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.3    Diagnostic laboratories

8.3.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.4    Homecare settings

8.4.1    Market estimates and forecast, 2018 - 2032 (USD Million)

8.5    Others

8.5.1    Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 9   Lateral Flow Assays Market, By Region

9.1    Key regional trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Poland

9.3.7    Switzerland

9.3.8    Netherlands

9.4    Asia Pacific

9.4.1    China

9.4.2    Japan

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Indonesia

9.4.7    Thailand

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    UAE

Chapter 10   Company Profiles

10.1    Abingdon Health

10.2    Abbott

10.3    Bio-Rad Laboratories

10.4    Bioeasy Biotechnology Inc.

10.5    bioMerieux SA

10.6    Hologic Inc.

10.7    F. Hoffmann La Roche

10.8    Thermo Fischer Scientific

10.9    OPERON, S.A.

10.10    Quidel Corporation
 

Authors: Mariam Faizullabhoy

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 10
  • Tables & Figures: 482
  • Countries covered: 23
  • Pages: 240
 Download PDF